Acyclovir alaninate

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 596757

CAS#: 84499-64-9

Description: Acyclovir alaninate is a pro-drug of Acyclovir. Acyclovir is a nucleic acid analog made from guanosine and is used in the treatment of chickenpox, shingles, and herpes simplex virus. Acyclovir works by decreasing the production of DNA of the virus and i shows very low cytotoxicity.

Chemical Structure

img
Acyclovir alaninate
CAS# 84499-64-9
Instruction

Theoretical Analysis

MedKoo Cat#: 596757
Name: Acyclovir alaninate
CAS#: 84499-64-9
Chemical Formula: C11H16N6O4
Exact Mass: 296.12
Molecular Weight: 296.280
Elemental Analysis: C, 44.59; H, 5.44; N, 28.37; O, 21.60

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Acyclovir alaninate; Valacyclovir hydrochloride, acyclovir alaninated- [USP];

IUPAC/Chemical Name: 2-((2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)ethyl L-alaninate

InChi Key: MUIRAGHHRGAJMO-LURJTMIESA-N

InChi Code: InChI=1S/C11H16N6O4/c1-6(12)10(19)21-3-2-20-5-17-4-14-7-8(17)15-11(13)16-9(7)18/h4,6H,2-3,5,12H2,1H3,(H3,13,15,16,18)/t6-/m0/s1

SMILES Code: N[C@@H](C)C(OCCOCN1C=NC2=C1N=C(N)NC2=O)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 296.28 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Kusulja M, Santini M. Decompressive craniectomy as salvage treatment in herpes simplex encephalitis: two case reports. Int J Infect Dis. 2018 Jun 2. pii: S1201-9712(18)34426-6. doi: 10.1016/j.ijid.2018.05.016. [Epub ahead of print] PubMed PMID: 29870796.

2: Tintori C, Iovenitti G, Ceresola ER, Ferrarese R, Zamperini C, Brai A, Poli G, Dreassi E, Cagno V, Lembo D, Canducci F, Botta M. Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides. PLoS One. 2018 Jun 5;13(6):e0198478. doi: 10.1371/journal.pone.0198478. eCollection 2018. PubMed PMID: 29870553.

3: White CN, Jones G, Baker S, Dean RS, Brennan ML. Variation in the Reported Management of Canine Prolapsed Nictitans Gland and Feline Herpetic Keratitis. Vet Sci. 2018 Jun 1;5(2). pii: E54. doi: 10.3390/vetsci5020054. PubMed PMID: 29865183.

4: Vallabhaneni D, Naveed MA, Mangla R, Zidan A, Mehta RI. Perfusion Imaging in Autoimmune Encephalitis. Case Rep Radiol. 2018 May 6;2018:3538645. doi: 10.1155/2018/3538645. eCollection 2018. PubMed PMID: 29854534; PubMed Central PMCID: PMC5960559.

5: Faqih NA, Alfaqih MA, Salami K, Herron B, Sultan I, Al-Hussaini M. Empirical treatment with parenteral acyclovir in a child with herpes simplex virus hepatitis and acute lymphoblastic leukemia. IDCases. 2018 Feb 21;12:10-12. doi: 10.1016/j.idcr.2018.02.006. eCollection 2018. PubMed PMID: 29850402; PubMed Central PMCID: PMC5966627.

6: Inagaki T, Satoh M, Fujii H, Yamada S, Shibamura M, Yoshikawa T, Harada S, Takeyama H, Saijo M. Acyclovir Sensitivity and Neurovirulence of Herpes Simplex Virus Type 1 with Amino Acid Substitutions in the Viral Thymidine Kinase Gene, Which Were Detected in the Patients with Intractable Herpes Simplex Encephalitis Previously Reported. Jpn J Infect Dis. 2018 May 31. doi: 10.7883/yoken.JJID.2018.176. [Epub ahead of print] PubMed PMID: 29848849.

7: Alexander KE, Tong PL, Macartney K, Beresford R, Sheppeard V, Gupta M. Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection. Vaccine. 2018 May 25. pii: S0264-410X(18)30744-8. doi: 10.1016/j.vaccine.2018.05.078. [Epub ahead of print] PubMed PMID: 29807711.

8: Siodlak M, Jorgenson MR, Descourouez JL, Leverson GE, Mandelbrot DA, Smith JA, Redfield RR. Impact of High-Dose Acyclovir Cytomegalovirus Prophylaxis Failure in Abdominal Solid Organ Transplant Recipients. Pharmacotherapy. 2018 May 25. doi: 10.1002/phar.2126. [Epub ahead of print] PubMed PMID: 29800500.

9: Vestergaard T. [Genital herpes]. Ugeskr Laeger. 2018 May 14;180(20). pii: V01180024. Danish. PubMed PMID: 29798750.

10: Pines N, Tsabari R, Kerem E, Reiter J. Herpes Simplex Virus Pneumonia in an Immunocompetent Child on Corticosteroids for Acute Wheezing. Pediatr Emerg Care. 2018 May 23. doi: 10.1097/PEC.0000000000001519. [Epub ahead of print] PubMed PMID: 29794958.

11: Lebrun M, Lambert J, Riva L, Thelen N, Rambout X, Blondeau C, Thiry M, Snoeck R, Twizere JC, Dequiedt F, Andrei G, Sadzot-Delvaux C. Varicella Zoster Virus ORF9p binding to cellular adaptor protein complex-1 is important for viral infectivity. J Virol. 2018 May 23. pii: JVI.00295-18. doi: 10.1128/JVI.00295-18. [Epub ahead of print] PubMed PMID: 29793951.

12: Uthayakumar A, Harrington D. Spontaneous splenic rupture complicating primary varicella zoster infection: a case report. BMC Res Notes. 2018 May 22;11(1):334. doi: 10.1186/s13104-018-3430-6. PubMed PMID: 29789000; PubMed Central PMCID: PMC5964893.

13: Mäkitie O, Vakkilainen S. Cartilage-Hair Hypoplasia – Anauxetic Dysplasia Spectrum Disorders. 2012 Mar 15 [updated 2018 May 24]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018. Available from http://www.ncbi.nlm.nih.gov/books/NBK84550/ PubMed PMID: 22420014.

14: Begolli Gerqari A, Ferizi M, Kotori M, Daka A, Hapciu S, Begolli I, Begolli M, Gerqari I. Activation of Herpes Simplex Infection after Tattoo. Acta Dermatovenerol Croat. 2018 Apr;26(1):75-76. PubMed PMID: 29782308.

15: Vissani MA, Zabal O, Tordoya MS, Parreño V, Thiry E, Barrandeguy M. In vitro comparison of acyclovir, ganciclovir and cidofovir against equid alphaherpesvirus 3 and evaluation of their efficacy against six field isolates. Rev Argent Microbiol. 2018 May 17. pii: S0325-7541(18)30005-1. doi: 10.1016/j.ram.2018.01.003. [Epub ahead of print] PubMed PMID: 29779880.

16: Chayrov RL, Stylos EK, Chatziathanasiadou MV, Chuchkov KN, Tencheva AI, Kostagianni AD, Milkova TS, Angelova AL, Galabov AS, Shishkov SA, Todorov DG, Tzakos AG, Stankova IG. Tailoring acyclovir prodrugs with enhanced antiviral activity: rational design, synthesis, human plasma stability and in vitro evaluation. Amino Acids. 2018 May 19. doi: 10.1007/s00726-018-2590-y. [Epub ahead of print] PubMed PMID: 29779181.

17: Abozaid D, Ramadan A, Barakat H, Khalafallah N. Acyclovir lipid nanocapsules gel for oromucosal delivery: A preclinical evidence of efficacy in the chicken pouch membrane model. Eur J Pharm Sci. 2018 May 17. pii: S0928-0987(18)30235-5. doi: 10.1016/j.ejps.2018.05.016. [Epub ahead of print] PubMed PMID: 29778782.

18: Gagelmann N, Ljungman P, Styczynski J, Kröger N. Comparative Efficacy and Safety of Different Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis. Biol Blood Marrow Transplant. 2018 May 16. pii: S1083-8791(18)30269-6. doi: 10.1016/j.bbmt.2018.05.017. [Epub ahead of print] PubMed PMID: 29777868.

19: Pamornpathomkul B, Ngawhirunpat T, Tekko IA, Vora L, McCarthy HO, Donnelly RF. Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery. Eur J Pharm Sci. 2018 May 16;121:200-209. doi: 10.1016/j.ejps.2018.05.009. [Epub ahead of print] PubMed PMID: 29777854.

20: Lubián López S, Pérez Guerrero JJ, Salazar Oliva P, Benavente Fernández I. [Neonatal facial palsy: identification of herpes simplex virus 1 in cerebrospinal fluid. Case report]. Arch Argent Pediatr. 2018 Jun 1;116(3):e468-e470. doi: 10.5546/aap.2018.e468. Spanish. PubMed PMID: 29756726.